Cargando…

Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells

Introduction: Engineered heart tissues (EHTs) are three-dimensional culture platforms with cardiomyocytes differentiated from human pluripotent stem cells (hPSCs) and were designed for assaying cardiac contractility. For drug development applications, EHTs must have a stable function and provide rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arefin, Ayesha, Mendoza, Melissa, Dame, Keri, Garcia, M. Iveth, Strauss, David G., Ribeiro, Alexandre J. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352809/ https://www.ncbi.nlm.nih.gov/pubmed/37469866 http://dx.doi.org/10.3389/fphar.2023.1212092

Ejemplares similares

Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation
por: Rubiano, Andrés, et al.
Publicado: (2021)

Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification
por: Lee, Eugene K., et al.
Publicado: (2017)

Human Engineered Heart Tissue: Analysis of Contractile Force
por: Mannhardt, Ingra, et al.
Publicado: (2016)

American ginseng acutely regulates contractile function of rat heart
por: Jiang, Mao, et al.
Publicado: (2014)

Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
por: Wu, Qin, et al.
Publicado: (2023)

Effects of Trandolapril on Structural, Contractile and Electrophysiological Remodeling in Experimental Volume Overload Heart Failure
por: Jarkovská, Dagmar, et al.
Publicado: (2021)

Correlation between frataxin expression and contractility revealed by in vitro Friedreich’s ataxia cardiac tissue models engineered from human pluripotent stem cells
por: Wong, Andy On-Tik, et al.
Publicado: (2019)

Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue
por: Stenzig, Justus, et al.
Publicado: (2022)

In vitro effect of hydroxychloroquine on pluripotent stem cells and their cardiomyocytes derivatives
por: Kamga Kapchoup, Michelle Vanessa, et al.
Publicado: (2023)

Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue
por: Sasaki, Daisuke, et al.
Publicado: (2018)

Integrated Isogenic Human Induced Pluripotent Stem Cell–Based Liver and Heart Microphysiological Systems Predict Unsafe Drug–Drug Interaction
por: Lee-Montiel, Felipe T., et al.
Publicado: (2021)

Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects
por: Dame, Keri, et al.
Publicado: (2020)

Lymphatic Collecting Vessel: New Perspectives on Mechanisms of Contractile Regulation and Potential Lymphatic Contractile Pathways to Target in Obesity and Metabolic Diseases
por: Lee, Yang, et al.
Publicado: (2022)

Sulforaphane exposure impairs contractility and mitochondrial function in three-dimensional engineered heart tissue
por: Rhoden, Alexandra, et al.
Publicado: (2021)

Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an MYH6 Head Domain Variant Associated With Hypoplastic Left Heart Syndrome
por: Kim, Min-Su, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles
por: Zhao, Shudong, et al.
Publicado: (2023)

Human pluripotent stem cells on artificial microenvironments: a high content perspective
por: Viswanathan, Priyalakshmi, et al.
Publicado: (2014)

Generation of high-performance human cardiomyocytes and engineered heart tissues from extended pluripotent stem cells
por: Li, Li, et al.
Publicado: (2022)

Effect of tetracycline hydrochloride application on dental pulp stem cell metabolism–booster or obstacle for tissue engineering?
por: Wang, Wang, et al.
Publicado: (2023)

Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue
por: Jacob, Fabian, et al.
Publicado: (2016)

Stem cell differentiation and expansion for clinical applications of tissue engineering
por: Guillot, Pascale V, et al.
Publicado: (2007)

New Modalities of 3D Pluripotent Stem Cell-Based Assays in Cardiovascular Toxicity
por: Orsolits, Barbara, et al.
Publicado: (2021)

Single‐Cell Transcriptomics of Engineered Cardiac Tissues From Patient‐Specific Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome
por: Lam, Yin‐Yu, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells Attenuate Cigarette Smoke-Induced Cardiac Remodeling and Dysfunction
por: Liang, Yingmin, et al.
Publicado: (2017)

Contractility analysis of human engineered 3D heart tissues by an automatic tracking technique using a standalone application
por: Rivera-Arbeláez, José M., et al.
Publicado: (2022)

Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues
por: Shadrin, Ilya Y., et al.
Publicado: (2017)

Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity
por: Tu, Chengyi, et al.
Publicado: (2021)

Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell–Derived Cardiomyocytes
por: Klimovic, Simon, et al.
Publicado: (2022)

Human Pluripotent Stem Cells for Modeling of Anticancer Therapy-Induced Cardiotoxicity and Cardioprotective Drug Discovery
por: Keung, Wendy, et al.
Publicado: (2021)

Neural tissue engineering using embryonic and induced pluripotent stem cells
por: Willerth, Stephanie M
Publicado: (2011)

Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells
por: Bucolo, Claudio, et al.
Publicado: (2012)

Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension
por: Altara, Raffaele, et al.
Publicado: (2016)

Correction: Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue
por: Jacob, Fabian, et al.
Publicado: (2018)

Full-length dystrophin deficiency leads to contractile and calcium transient defects in human engineered heart tissues
por: Bremner, Samantha B, et al.
Publicado: (2022)

Effects of Substrate Mechanics on Contractility of Cardiomyocytes Generated from Human Pluripotent Stem Cells
por: Hazeltine, Laurie B., et al.
Publicado: (2012)

Development of a Contractile Cardiac Fiber From Pluripotent Stem Cell Derived Cardiomyocytes
por: Hansen, Katrina J., et al.
Publicado: (2018)

Editorial: New exploration for therapeutic tissue engineering grafts in the field of tissue regeneration
por: Yu, Tianhao, et al.
Publicado: (2023)

Evaluation of mouse urinary bladder smooth muscle for diurnal differences in contractile properties
por: White, Rachel S., et al.
Publicado: (2015)

Scaffold-Based Gene Therapeutics for Osteochondral Tissue Engineering
por: Yan, Xin, et al.
Publicado: (2020)

Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes
por: Goldfracht, Idit, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cu27p0d9k1kmkoti70m2hofjpc